Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Zymeworks Inc.(ZYME) | 22,970,388 | 22,970,388 | 0 | $575.18M | $600.45M | 29.77% | +$25.27M |
| Anaptysbio Inc | 7,880,094 | 7,880,094 | 0 | $437.03M | $531.91M | 26.37% | +$94.88M |
| Aktis Oncology, Inc.(AKTS) | 4,824,469 | 4,824,469 | 0 | $86.31M | $155.49M | 7.71% | +$69.18M |
| CG Oncology, Inc.(CGON) | 1,102,000 | 1,494,300 | +392,300 | $74.58M | $106.17M | 5.26% | +$31.59M |
| Eton Pharmaceuticals, Inc.(ETON) | 2,171,938 | 2,171,938 | 0 | $53.60M | $78.62M | 3.90% | +$25.02M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 1,389,276 | 1,389,276 | 0 | $66.09M | $75.77M | 3.76% | +$9.68M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 6,728,116 | 6,728,116 | 0 | $85.25M | $72.87M | 3.61% | -$12.38M |
| First Tracks BiotherapeuticsORD SHS ADDED | 0 | 3,174,519 | +3,174,519 | $0 | $63.87M | 3.17% | +$63.87M |
| Lakefront Biotherapeutics NVADR(LKFT) | 1,667,119 | 1,667,119 | 0 | $50.01M | $49.98M | 2.48% | -$33.3K |
| Neurogene Inc.(NGNE) | 1,271,342 | 1,271,342 | 0 | $25.63M | $39.98M | 1.98% | +$14.35M |
| Stoke Therapeutics, Inc.(STOK) | 100,000 | 735,000 | +635,000 | $3.26M | $24.05M | 1.19% | +$20.79M |
| Fulcrum Therapeutics, Inc.(FULC) | 0 | 6,549,866 | +6,549,866 | $0 | $23.97M | 1.19% | +$23.97M |
| Legend Biotech CorporationADS(LEGN) | 0 | 800,000 | +800,000 | $0 | $23.10M | 1.15% | +$23.10M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 2,823,126 | 2,823,126 | 0 | $25.27M | $21.51M | 1.07% | -$3.75M |
| MBX Biosciences, Inc.(MBX) | 777,000 | 388,500 | -388,500 | $23.19M | $21.45M | 1.06% | -$1.75M |
| Zenas BioPharma, Inc.(ZBIO) | 789,500 | 789,500 | 0 | $15.43M | $20.04M | 0.99% | +$4.60M |
| Atara Biotherapeutics Inc | 99,593 | 1,552,000 | +1,452,407 | $471.1K | $17.82M | 0.88% | +$17.35M |
| Relay Therapeutics, Inc.(RLAY) | 1,904,762 | 697,948 | -1,206,814 | $18.95M | $13.06M | 0.65% | -$5.89M |
| Aura Biosciences, Inc.(AURA) | 0 | 1,666,667 | +1,666,667 | $0 | $11.83M | 0.59% | +$11.83M |
| Odyssey Therapeutics IncCOMMON STOCK ADDED | 0 | 555,555 | +555,555 | $0 | $10.39M | 0.52% | +$10.39M |
| Eikon Therapeutics, Inc.(EIKN) | 732,606 | 732,606 | 0 | $7.75M | $9.56M | 0.47% | +$1.81M |
| Pharvaris N V COM | 0 | 235,000 | +235,000 | $0 | $8.13M | 0.40% | +$8.13M |
| Zura Bio LimitedCL A(ZURA) | 1,179,715 | 1,179,715 | 0 | $7.02M | $6.96M | 0.35% | -$59.0K |
| Phathom Pharmaceuticals, Inc.(PHAT) | 625,000 | 625,000 | 0 | $6.94M | $6.78M | 0.34% | -$162.5K |
| Nurix Therapeutics, Inc.(NRIX) | 0 | 270,000 | +270,000 | $0 | $6.55M | 0.32% | +$6.55M |
| Erasca, Inc.(ERAS) | 900,000 | 330,000 | -570,000 | $14.56M | $6.05M | 0.30% | -$8.52M |
| Eloxx Pharmaceuticals IncCOM NEW ADDED | 0 | 400,000 | +400,000 | $0 | $5.55M | 0.28% | +$5.55M |
| Aardvark Therapeutics Inc | 0 | 396,194 | +396,194 | $0 | $2.28M | 0.11% | +$2.28M |
| Helix Acquisition Corp. IIICL A(HLXC) | 200,000 | 200,000 | 0 | $2.03M | $2.13M | 0.11% | +$96.0K |
| Mereo BioPharma Group plcADS(MREO) | 13,368,855 | 1,000,000 | -12,368,855 | $4.41M | $317.7K | 0.02% | -$4.09M |
| Surrozen, Inc.W EXP 08 01 203(SRZN) | 4,444 | 4,444 | 0 | $129.5K | $115.3K | 0.01% | -$14.1K |
| Centessa Pharmaceuticals PlcADS | 6,000,000 | 0 | -6,000,000 | $238.32M | $0 | — | -$238.32M |
| Crinetics Pharmaceuticals In | 4,288,120 | 0 | -4,288,120 | $155.74M | $0 | — | -$155.74M |
| iBio, Inc.(IBIO) | 1,583,000 | 0 | -1,583,000 | $3.01M | $0 | — | -$3.01M |
| Jazz Pharmaceuticals plcSHS USD(JAZZ) | 1,706,469 | 0 | -1,706,469 | $322.61M | $0 | — | -$322.61M |
| Prelude Therapeutics Incorporated(PRLD) | 947,049 | 0 | -947,049 | $3.24M | $0 | — | -$3.24M |
| Replimune Group, Inc.(REPL) | 1,000,000 | 0 | -1,000,000 | $7.65M | $0 | — | -$7.65M |
| Xencor, Inc.(XNCR) | 2,183,000 | 0 | -2,183,000 | $26.33M | $0 | — | -$26.33M |